Mariner
ORTX

Mariner’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Mariner’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-192,250
Closed -$1.49M – 3207
2023
Q3 		$1.49M Buy
192,250
+37,840
+25% +$205K ﹤0.01% 1123
2023
Q2 		$804K Buy
154,410
+68,103
+79% +$347K ﹤0.01% 1435
2023
Q1 		$463K Buy
86,307
+23,209
+37% +$126K ﹤0.01% 1754
2022
Q4 		$234K Buy
+63,098
New +$279K ﹤0.01% 2232

Other funds holding ORTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Mariner's ORTX Position: Q4 2023 in Review

Mariner sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 192,250 shares — an estimated $1.49M sold.

Mariner first reported a position in ORTX in Q4 2022 and held it in 4 quarters. The position peaked at $1.49M in Q3 2023. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

  • Mariner reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Mariner sold 192,250 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $1.49M.
  • Mariner first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2022 and held it in 4 quarters.
  • Mariner's Orchard Therapeutics plc American Depositary Shares position peaked at $1.49M in Q3 2023.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on Mariner's 13F filing for Q4 2023, filed 14 Feb 2024.